Switch to
More onapp

Dipna Pharmachem Ltd

DPL
Trading
SmallcapWith a market cap of ₹25 cr, stock is ranked 3,061
High RiskStock is 3.89x as volatile as Nifty
21.500.50 (+2.38%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Trading
SmallcapWith a market cap of ₹25 cr, stock is ranked 3,061
High RiskStock is 3.89x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
21.67
PB RatioPB Ratio
14.45
Dividend YieldDiv. Yield
Sector PESector PE
88.15
Sector PBSector PB
11.22
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dipna Pharmachem Limited is an India-based trader, importer, and exporter of industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulations. The Company's product portfolio comprises approximately 61 APIs and AIPs intermediates, such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone and others. Its products include Aceclofenac, Asprin, Acetazolamide, Albendazole, Ambroxol HCL, Amisulpride IP/BP, Amoxicillin, Aripiprazole IP, Artemether, Azithromycin, Hydrocortisone Acetate, Ibuprofen Ip, Levofloxacin. Lumefantrine, Lidocaine Base, Lidocaine Hydrochloride, Lornoxicam, L Glutathione Reduced, L Glutamine, L Carnosine, L Arginine Base and others. It provides import/export services to clients throughout the world.

Financial TrendFinancial statements 

201920202021202220.1930.5531.0272.770.040.070.031.16
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Hmm, looks like data is unavailable here. Please come back after some time
See all events